With this support, the EMA aims to facilitate the development and implementation of so-called New Approach Methods (NAMs). The ITF is a multidisciplinary group for early dialogue between regulatory authorities and drug developers; it aims to facilitate the integration of appropriate NAMs.
According to the EMA's website, the measure is in line with the EMA's Science Strategy for Regulation by 2025.
Source and further information:
https://www.ema.europa.eu/en/news/ema-implements-new-measures-minimise-animal-testing-during-medicines-development
EMA Science Strategy:
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ema-regulatory-science-2025-strategic-reflection_en.pdf
https://www.ema.europa.eu/en/documents/minutes/minutes-107th-meeting-management-board-19-march-2020_en.pdf